Zymeworks Inc. (ZYME) stock
ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30117% above fair value
$26.24−0.23 (-0.87%)
Close on Nov 13, 2026Market cap $1.86BP/E 50.5Yield –
Zymeworks pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Zymeworks's pe ratio was 3.5× on Jan 31, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 3.5× | +0.1 |
| 2023 | Dec 29, 2023 | 3.4× | – |
See a number that looks wrong?